Return to content in this issue

Unsustained Response to Benralizumab in Eosinophilic Asthma After 3 Years of Therapy With Mepolizumab

Kurosawa M¹, Shimizu Y², Sutoh Y³, Sutoh E<sup>1,3

1</sup>Department of Allergy and Respiratory Medicine, Sutoh Hospital, Annaka, Gunma, Japan
²Division of Respiratory Medicine, Kaminakai Family Clinic, Takasaki, Gunma, Japan
³Department of Surgery, Sutoh Hospital, Annaka, Gunma, Japan

J Investig Allergol Clin Immunol 2021; Vol 31(4) : 353-355
doi: 10.18176/jiaci.0652